Epstein–Barr Virus Seroprevalence in Thailand: A Temporal and Global Perspective with Health Care and Economic Correlations

Lita Tantipraphat Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;
Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;

Search for other papers by Lita Tantipraphat in
Current site
Google Scholar
PubMed
Close
,
Narakit Sudhinaraset Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;
Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;

Search for other papers by Narakit Sudhinaraset in
Current site
Google Scholar
PubMed
Close
,
Thanunrat Thongmee Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;

Search for other papers by Thanunrat Thongmee in
Current site
Google Scholar
PubMed
Close
,
Sitthichai Kanokudom Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;

Search for other papers by Sitthichai Kanokudom in
Current site
Google Scholar
PubMed
Close
,
Pornjarim Nilyanimit Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;

Search for other papers by Pornjarim Nilyanimit in
Current site
Google Scholar
PubMed
Close
,
Natthinee Sudhinaraset Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;

Search for other papers by Natthinee Sudhinaraset in
Current site
Google Scholar
PubMed
Close
, and
Yong Poovorawan Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;
The Royal Society of Thailand, Bangkok, Thailand

Search for other papers by Yong Poovorawan in
Current site
Google Scholar
PubMed
Close
Restricted access

Epstein–Barr virus (EBV) infects over 90% of the global population and establishes lifelong persistence. Although early childhood infections are often asymptomatic, EBV infection during adolescence can cause infectious mononucleosis, several malignancies, and posttransplant lymphoproliferative disorders. The timing of EBV infection and seroprevalence varies globally based on geographic and socioeconomic factors; however, comprehensive and updated data for Thailand are limited. This study investigated EBV seroprevalence across age groups in four provinces representing Thailand’s regions, comparing findings with previous data and exploring correlations with economic and health care indicators. Serum samples (N = 1,274) were collected between May and August 2024 from participants ages 6 months old to 80 years old in Ayutthaya, Uttaradit, Buri Ram, and Trang provinces. EBV capsid antigen IgG levels were measured using ELISA. Age-specific seroprevalence increased from 35.9% in infants (6 months old to 2 years old) to nearly 100% in adolescents and adults, with varying antibody levels between age groups. Comparisons with historical data illustrated consistent trends of early EBV acquisition in childhood, but the infection increased slightly slower than in the past. Compared with other countries, EBV seroprevalence in Thailand and other developing countries occurred earlier than in developed countries. Linear regression analysis revealed a significant correlation between age at 50% and 75% EBV seropositive and a national economic indicator (gross domestic product per capita). These findings found little changes in EBV epidemiology over time and provided updated information and analysis to support public health strategies.

Author Notes

Financial support: This study was financially supported by the Pink Diamond Project, Faculty of Medicine, Chulalongkorn University; the MK Restaurant Group Aunt Thongkum Foundation; the Education and Public Welfare Foundation; the Center of Excellence in Clinical Virology, Chulalongkorn University; and the King Chulalongkorn Memorial Hospital.

Disclosures: The authors declare no conflicts of interest. The datasets generated and analyzed during the current study are available from the corresponding author upon reasonable request.

Authors’ contributions: All authors were involved in the conception and design of the study. S. Kanokudom and P. Nilyanimit collected specimens and data. L. Tantipraphat and T. Thongmee performed the laboratory tests. L. Tantipraphat, Narakit Sudhinaraset, and Natthinee Sudhinaraset analyzed the data. L. Tantipraphat, Narakit Sudhinaraset, and S. Kanokudom developed visualization of the data. L. Tantipraphat, Narakit Sudhinaraset, Natthinee Sudhinaraset, and Y. Poovorawan drafted the manuscript. All authors critically revised the manuscript for intellectual content and approved the version to be published. All authors agree to be accountable for all aspects of the work.

Current contact information: Lita Tantipraphat, Narakit Sudhinaraset, Thanunrat Thongmee, Sitthichai Kanokudom, Pornjarim Nilyanimit, Natthinee Sudhinaraset, and Yong Poovorawan, Center of Excellence in Clinical Virology, Chulalongkorn University, Bangkok, Thailand, E-mails: litatanti@docchula.com, narakit.sud@docchula.com, tata033@hotmail.com, sitthichai.k@chula.ac.th, mim_bhni@hotmail.com, dr_natthinee@hotmail.com, and yong.p@chula.ac.th.

Address correspondence to Yong Poovorawan, Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Rd., Pathum Wan, Bangkok 10330, Thailand. E-mail: yong.p@chula.ac.th
Past two years Past Year Past 30 Days
Abstract Views 464 464 464
Full Text Views 51 51 51
PDF Downloads 50 50 50
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save